3.02
Orasure Technologies Inc stock is traded at $3.02, with a volume of 798.10K.
It is up +5.23% in the last 24 hours and up +19.84% over the past month.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
See More
Previous Close:
$2.87
Open:
$2.89
24h Volume:
798.10K
Relative Volume:
1.16
Market Cap:
$223.65M
Revenue:
$405.47M
Net Income/Loss:
$53.66M
P/E Ratio:
4.1944
EPS:
0.72
Net Cash Flow:
$131.28M
1W Performance:
+4.86%
1M Performance:
+19.84%
6M Performance:
-17.03%
1Y Performance:
-28.10%
Orasure Technologies Inc Stock (OSUR) Company Profile
Name
Orasure Technologies Inc
Sector
Industry
Phone
(503) 641-6115
Address
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
OSUR
Orasure Technologies Inc
|
3.02 | 223.65M | 405.47M | 53.66M | 131.28M | 0.72 |
![]()
ISRG
Intuitive Surgical Inc
|
534.19 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
169.97 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
87.11 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
256.21 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
219.00 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-03-23 | Resumed | Evercore ISI | In-line |
Sep-22-21 | Downgrade | Raymond James | Outperform → Mkt Perform |
Aug-21-20 | Initiated | Evercore ISI | Outperform |
Aug-10-20 | Initiated | Citigroup | Buy |
Aug-10-20 | Initiated | JP Morgan | Neutral |
Aug-07-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
Jun-25-20 | Initiated | Lake Street | Buy |
Apr-21-20 | Resumed | Stephens | Equal-Weight |
Oct-23-18 | Resumed | Raymond James | Mkt Perform |
Jul-16-18 | Downgrade | Stephens | Overweight → Equal-Weight |
Nov-02-17 | Downgrade | Jefferies | Buy → Hold |
Feb-09-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
Jun-13-16 | Downgrade | Raymond James | Outperform → Mkt Perform |
Nov-05-15 | Reiterated | Mizuho | Buy |
May-07-15 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
Jan-23-15 | Reiterated | Mizuho | Buy |
Jun-12-14 | Reiterated | Canaccord Genuity | Buy |
Jun-11-14 | Reiterated | Mizuho | Buy |
Dec-21-12 | Initiated | Mizuho | Buy |
Aug-08-12 | Upgrade | Barrington Research | Mkt Perform → Outperform |
Jul-05-12 | Downgrade | Barrington Research | Outperform → Mkt Perform |
Mar-27-12 | Initiated | JMP Securities | Mkt Outperform |
View All
Orasure Technologies Inc Stock (OSUR) Latest News
Investor Network: OraSure Technologies, Inc. to Host Earnings Call - ACCESS Newswire
Robust Growth in Medtech Registration System Market - openPR.com
Two Sigma Investments LP Takes $552,000 Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Public Employees Retirement System of Ohio Acquires Shares of 76,602 OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Two Sigma Advisers LP Boosts Holdings in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Ameriprise Financial Inc. Has $628,000 Stake in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Purchased by ProShare Advisors LLC - Defense World
Top Penny Stocks To Watch In May 2025 - simplywall.st
OraSure Technologies: Multiple Shots To Deliver Value (NASDAQ:OSUR) - Seeking Alpha
Millennium Management LLC Has $7.79 Million Stake in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Orasure Technologies Inc Files For Mixed Shelf Of Up To $300 MillionSEC Filing - marketscreener.com
OraSure (OSUR) Files for $300 Million Mixed Securities Offering - GuruFocus
Evercore says 23andMe buyout removes downside case for OraSure - Yahoo Finance
OraSure Technologies (NASDAQ:OSUR) Receives “In-Line” Rating from Evercore ISI - Defense World
Jane Street Group LLC Has $1.47 Million Stock Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure rises as seen benefitting from 23andMe/Regeneron deal - MSN
OraSure Technologies (OSUR) Rises on Regeneron-23andMe Deal - GuruFocus
OraSure stock rises following Regeneron’s 23andMe acquisition - Investing.com
OraSure Technologies (OSUR) Maintains In-Line Rating with Everco - GuruFocus
Hold Rating on Orasure Technologies Amid 23andMe Acquisition and Revenue Uncertainties - TipRanks
OraSure (OSUR) Sees Positive Outlook with 23andMe Partnership | - GuruFocus
OraSure Technologies (OSUR) Sees Positive Market Reaction | OSUR Stock News - GuruFocus
OraSure (OSUR) Sees Positive Outlook with 23andMe Partnership | OSUR Stock News - GuruFocus
OraSure’s Board of Directors has a new Member Stephen S. Tang, Ph.D., has joined OraSure T - Medical Product Outsourcing
OraSure Technologies (NASDAQ:OSUR) Raised to Hold at StockNews.com - Defense World
Tower Research Capital LLC TRC Grows Position in OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
Targeted Genomics, OraSure in pact for at-home celiac genetic testing - MSN
10,227 Shares in OraSure Technologies, Inc. (NASDAQ:OSUR) Bought by Raymond James Financial Inc. - Defense World
Voya Investment Management LLC Sells 28,998 Shares of OraSure Technologies, Inc. (NASDAQ:OSUR) - Defense World
OraSure Technologies Approves Stock Plan Amendment at Annual Meeting - TipRanks
OraSure, Targeted Genomics in pact for at-home celiac genetic testing - Seeking Alpha
OraSure Technologies (OSUR) Partners to Enhance At-Home Celiac T - GuruFocus
Targeted Genomics Announces Commercial Collaboration with - GlobeNewswire
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing - The Manila Times
OraSure Technologies (NASDAQ:OSUR) Cut to Sell at StockNews.com - Defense World
Orasure technologies outlines Q2 2025 revenue guidance of $28.5M-$32.5M amid new product launches and customer expansions - MSN
OraSure Executive Resigns, Effective June 30 - Investing.com
OraSure Executive Resigns, Effective June 30 By Investing.com - Investing.com India
OraSure Technologies First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2025 Earnings Call Transcript - Insider Monkey
OraSure Technologies Announces CPO Resignation - TipRanks
Orasure Technologies, Inc. Announces Resignation of Chief Product Officer Kathleen G. Weber Effective June 30, 2025 - marketscreener.com
OraSure Technologies, Inc. (NASDAQ:OSUR) Shares Sold by Envestnet Asset Management Inc. - Defense World
Evercore ISI cuts OraSure stock price target to $3 from $4 - Investing.com Nigeria
Shareholders Will Probably Hold Off On Increasing OraSure Technologies, Inc.'s (NASDAQ:OSUR) CEO Compensation For The Time Being - simplywall.st
Earnings call transcript: OraSure’s Q1 2025 beats EPS forecast, stock stable - Investing.com Nigeria
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... - Yahoo Finance
OraSure Technologies Inc (OSUR) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - GuruFocus
OraSure Technologies Reports Q1 2025 Financial Results - TipRanks
OraSure: Q1 Earnings Snapshot - The Washington Post
Orasure Technologies Inc Stock (OSUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Orasure Technologies Inc Stock (OSUR) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
EGLINTON MANNER CARRIE | President & CEO |
Feb 28 '25 |
Buy |
3.49 |
28,670 |
100,027 |
1,288,334 |
EGLINTON MANNER CARRIE | President & CEO |
Feb 27 '25 |
Buy |
3.15 |
78,625 |
247,378 |
1,259,664 |
Kenny John P. | Director |
Feb 27 '25 |
Buy |
3.17 |
47,659 |
151,217 |
70,915 |
McGrath Kenneth J | Chief Financial Officer |
Feb 27 '25 |
Buy |
3.15 |
64,000 |
201,683 |
371,013 |
Marmora Lelio | Director |
Feb 27 '25 |
Buy |
3.06 |
7,000 |
21,420 |
67,720 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):